1. Home
  2. IOVA vs BLSH Comparison

IOVA vs BLSH Comparison

Compare IOVA & BLSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$7.41

Market Cap

6.7B

Sector

Health Care

ML Signal

N/A

Logo Bullish Ordinary Shares

BLSH

Bullish Ordinary Shares

N/A

Current Price

$19.76

Market Cap

5.8B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IOVA
BLSH
Founded
2007
2020
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
5.8B
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
IOVA
BLSH
Price
$7.41
$19.76
Analyst Decision
Buy
Buy
Analyst Count
9
14
Target Price
$14.50
★ $36.15
AVG Volume (30 Days)
★ 12.8M
1.5M
Earning Date
11-05-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.84
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$58.86
$49.48
Revenue Next Year
$41.86
$12.47
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.08
$18.80
52 Week High
$15.37
$48.93

Technical Indicators

Market Signals
Indicator
IOVA
BLSH
Relative Strength Index (RSI) 31.10 32.55
Support Level $3.57 N/A
Resistance Level $9.36 $25.01
Average True Range (ATR) 0.57 1.69
MACD -0.13 -0.10
Stochastic Oscillator 4.34 11.35

Price Performance

Historical Comparison
IOVA
BLSH

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About BLSH Bullish Ordinary Shares

Bullish is an institutionally focused global digital asset platform focused on providing market infrastructure and information services. Its objective is to provide mission critical products and services that are designed to help institutions grow their businesses, empower individual investors, and drive the adoption of stablecoins, digital assets, and blockchain technology. It expanded its product offering to provide trusted insights, authoritative news, data, indices and transparent analysis to the digital assets industry while facilitating partnerships, investment opportunities, and community engagement through its flagship Consensus conference.

Share on Social Networks: